Translating new treatments for brain tumors
SPORE for Translational Approaches to Brain Cancer
['FUNDING_OTHER'] · NORTHWESTERN UNIVERSITY · NIH-11187066
This program brings doctors and researchers together to create and test new treatment options for people with glioblastoma and other brain tumors.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-11187066 on ClinicalTrials.gov |
What this research studies
From a patient point of view, a multidisciplinary team at Northwestern combines surgery, drug development, immune therapies, and laboratory studies to turn lab findings into treatments you could access. They collect tumor samples and clinical information, run lab and animal work to find promising approaches, and advance the most hopeful therapies into early clinical trials. Several projects run in parallel so discoveries can move more quickly from the lab to patients. If you have a brain tumor, this program aims to expand the treatment and trial options available at Northwestern.
Who could benefit from this research
Good fit: People with glioblastoma or other primary brain tumors who are treated at or can travel to Northwestern and who may be eligible for clinical trials or tissue donation.
Not a fit: Individuals without primary brain tumors or those unable to access Northwestern or its affiliated trial sites are unlikely to receive direct benefit from this program.
Why it matters
Potential benefit: Could produce new clinical trials and treatments that improve survival and quality of life for people with brain tumors.
How similar studies have performed: Previous SPORE and translational programs have generated promising clinical trials for brain cancer, but glioblastoma remains challenging and many approaches are still experimental.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LESNIAK, MACIEJ S — NORTHWESTERN UNIVERSITY
- Study coordinator: LESNIAK, MACIEJ S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Brain Cancer